NM_005360.5(MAF):c.768C>G (p.His256Gln) |
single nucleotide variant |
Cataract 21 multiple types [RCV000555075] |
Chr16:79599135 [GRCh38] Chr16:79633032 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.611G>T (p.Gly204Val) |
single nucleotide variant |
Cataract 21 multiple types [RCV000556258]|Inborn genetic diseases [RCV002526706]|not provided [RCV001692191] |
Chr16:79599292 [GRCh38] Chr16:79633189 [GRCh37] Chr16:16q23.2 |
benign |
NM_016373.4(WWOX):c.1238C>G (p.Ser413Cys) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV000530623]|not provided [RCV005241376] |
Chr16:79211789 [GRCh38] Chr16:79245686 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.696_710del (p.Gly234_Gly238del) |
deletion |
Cataract 21 multiple types [RCV000525623]|Inborn genetic diseases [RCV002525313]|not provided [RCV003424143] |
Chr16:79599193..79599207 [GRCh38] Chr16:79633090..79633104 [GRCh37] Chr16:16q23.2 |
likely benign|uncertain significance |
NM_016373.4(WWOX):c.1188C>A (p.Thr396=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV000542127] |
Chr16:79211739 [GRCh38] Chr16:79245636 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1114G>T (p.Gly372Ter) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV000703935]|See cases [RCV002252153]|not provided [RCV000519379] |
Chr16:79211665 [GRCh38] Chr16:79245562 [GRCh37] Chr16:16q23.2 |
pathogenic|likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance |
NM_005360.5(MAF):c.905C>T (p.Ala302Val) |
single nucleotide variant |
Cataract 21 multiple types [RCV000533204]|Cataract 21 multiple types [RCV003486884] |
Chr16:79598998 [GRCh38] Chr16:79632895 [GRCh37] Chr16:16q23.2 |
likely pathogenic|uncertain significance |
GRCh38/hg38 16q23.1-24.3(chr16:78816291-90081985)x3 |
copy number gain |
See cases [RCV000050840] |
Chr16:78816291..90081985 [GRCh38] Chr16:78850188..90148393 [GRCh37] Chr16:77407689..88675894 [NCBI36] Chr16:16q23.1-24.3 |
pathogenic |
GRCh38/hg38 16q23.2(chr16:79455147-81109328)x1 |
copy number loss |
See cases [RCV000050712] |
Chr16:79455147..81109328 [GRCh38] Chr16:79489044..81142933 [GRCh37] Chr16:78046545..79700434 [NCBI36] Chr16:16q23.2 |
pathogenic |
GRCh38/hg38 16q22.1-24.3(chr16:70514631-90081985)x3 |
copy number gain |
See cases [RCV000052422] |
Chr16:70514631..90081985 [GRCh38] Chr16:70548534..90148393 [GRCh37] Chr16:69106035..88675894 [NCBI36] Chr16:16q22.1-24.3 |
pathogenic |
GRCh38/hg38 16q23.1-24.3(chr16:76873569-90081985)x3 |
copy number gain |
See cases [RCV000052423] |
Chr16:76873569..90081985 [GRCh38] Chr16:76907466..90148393 [GRCh37] Chr16:75464967..88675894 [NCBI36] Chr16:16q23.1-24.3 |
pathogenic |
GRCh38/hg38 16q22.3-23.3(chr16:73049467-82576326)x1 |
copy number loss |
See cases [RCV000053357] |
Chr16:73049467..82576326 [GRCh38] Chr16:73083366..82609931 [GRCh37] Chr16:71640867..81167432 [NCBI36] Chr16:16q22.3-23.3 |
pathogenic |
NM_005360.5(MAF):c.1132C>A (p.Arg378Ser) |
single nucleotide variant |
not provided [RCV001507349] |
Chr16:79594540 [GRCh38] Chr16:79628437 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.908A>C (p.Gln303Pro) |
single nucleotide variant |
Cataract 21 multiple types [RCV000170459] |
Chr16:79598995 [GRCh38] Chr16:79632892 [GRCh37] Chr16:16q23.2 |
pathogenic |
GRCh38/hg38 16q22.1-24.1(chr16:70414573-84908120)x1 |
copy number loss |
See cases [RCV000133814] |
Chr16:70414573..84908120 [GRCh38] Chr16:70448476..84941726 [GRCh37] Chr16:69005977..83499227 [NCBI36] Chr16:16q22.1-24.1 |
pathogenic |
GRCh38/hg38 16q23.1-23.3(chr16:78790450-83255421)x1 |
copy number loss |
See cases [RCV000135302] |
Chr16:78790450..83255421 [GRCh38] Chr16:78824347..83289026 [GRCh37] Chr16:77381848..81846527 [NCBI36] Chr16:16q23.1-23.3 |
pathogenic |
GRCh38/hg38 16q21-24.1(chr16:62925929-84585795)x3 |
copy number gain |
See cases [RCV000135863] |
Chr16:62925929..84585795 [GRCh38] Chr16:62959833..84619401 [GRCh37] Chr16:61517334..83176902 [NCBI36] Chr16:16q21-24.1 |
pathogenic |
GRCh38/hg38 16q22.1-24.3(chr16:70749398-90096995)x3 |
copy number gain |
See cases [RCV000137495] |
Chr16:70749398..90096995 [GRCh38] Chr16:70783301..90163403 [GRCh37] Chr16:69340802..88690904 [NCBI36] Chr16:16q22.1-24.3 |
pathogenic |
GRCh38/hg38 16q21-24.3(chr16:65511483-90096995)x3 |
copy number gain |
See cases [RCV000139426] |
Chr16:65511483..90096995 [GRCh38] Chr16:65545386..90163403 [GRCh37] Chr16:64102887..88690904 [NCBI36] Chr16:16q21-24.3 |
pathogenic |
GRCh38/hg38 16q23.1-24.3(chr16:75377981-90081992)x3 |
copy number gain |
See cases [RCV000139302] |
Chr16:75377981..90081992 [GRCh38] Chr16:75411879..90148400 [GRCh37] Chr16:73969380..88675901 [NCBI36] Chr16:16q23.1-24.3 |
pathogenic |
GRCh38/hg38 16q23.1-24.3(chr16:76336203-90088654)x3 |
copy number gain |
See cases [RCV000141700] |
Chr16:76336203..90088654 [GRCh38] Chr16:76370100..90155062 [GRCh37] Chr16:74927601..88682563 [NCBI36] Chr16:16q23.1-24.3 |
pathogenic |
GRCh38/hg38 16q22.1-23.3(chr16:69053457-83274681)x3 |
copy number gain |
See cases [RCV000142038] |
Chr16:69053457..83274681 [GRCh38] Chr16:69087360..83308286 [GRCh37] Chr16:67644861..81865787 [NCBI36] Chr16:16q22.1-23.3 |
pathogenic |
GRCh38/hg38 16q21-23.3(chr16:65957829-83611443)x3 |
copy number gain |
See cases [RCV000143742] |
Chr16:65957829..83611443 [GRCh38] Chr16:65991732..83645048 [GRCh37] Chr16:64549233..82202549 [NCBI36] Chr16:16q21-23.3 |
pathogenic |
NM_005360.5(MAF):c.161C>T (p.Ser54Leu) |
single nucleotide variant |
Ayme-Gripp syndrome [RCV000149902]|MAF-related disorder [RCV004754316]|not provided [RCV003153434] |
Chr16:79599742 [GRCh38] Chr16:79633639 [GRCh37] Chr16:16q23.2 |
pathogenic |
NM_005360.5(MAF):c.863G>C (p.Arg288Pro) |
single nucleotide variant |
Cataract 21 multiple types [RCV000014136] |
Chr16:79599040 [GRCh38] Chr16:79632937 [GRCh37] Chr16:16q23.2 |
pathogenic |
NM_005360.5(MAF):c.890A>G (p.Lys297Arg) |
single nucleotide variant |
Cataract 21 multiple types [RCV000014137] |
Chr16:79599013 [GRCh38] Chr16:79632910 [GRCh37] Chr16:16q23.2 |
pathogenic |
GRCh38/hg38 16q21-24.3(chr16:65313395-90081985)x3 |
copy number gain |
See cases [RCV000052421] |
Chr16:65313395..90081985 [GRCh38] Chr16:65347298..90148393 [GRCh37] Chr16:63904799..88675894 [NCBI36] Chr16:16q21-24.3 |
pathogenic |
GRCh38/hg38 16q23.1-24.2(chr16:78704275-87819342)x1 |
copy number loss |
See cases [RCV000053359] |
Chr16:78704275..87819342 [GRCh38] Chr16:78738172..87852948 [GRCh37] Chr16:77295673..86410449 [NCBI36] Chr16:16q23.1-24.2 |
pathogenic |
NM_005360.5(MAF):c.895C>A (p.Arg299Ser) |
single nucleotide variant |
Cataract 21 multiple types [RCV000170458]|not provided [RCV002223802] |
Chr16:79599008 [GRCh38] Chr16:79632905 [GRCh37] Chr16:16q23.2 |
pathogenic|likely pathogenic |
GRCh38/hg38 16q21-24.3(chr16:64389378-90081985)x3 |
copy number gain |
See cases [RCV000142578] |
Chr16:64389378..90081985 [GRCh38] Chr16:64423281..90148393 [GRCh37] Chr16:62980782..88675894 [NCBI36] Chr16:16q21-24.3 |
pathogenic|likely pathogenic |
GRCh38/hg38 16q12.2-24.3(chr16:52899183-90088654)x3 |
copy number gain |
See cases [RCV000143425] |
Chr16:52899183..90088654 [GRCh38] Chr16:52933095..90155062 [GRCh37] Chr16:51490596..88682563 [NCBI36] Chr16:16q12.2-24.3 |
pathogenic |
NM_005360.5(MAF):c.172A>G (p.Thr58Ala) |
single nucleotide variant |
Ayme-Gripp syndrome [RCV000149903] |
Chr16:79599731 [GRCh38] Chr16:79633628 [GRCh37] Chr16:16q23.2 |
pathogenic |
NM_005360.5(MAF):c.173C>T (p.Thr58Ile) |
single nucleotide variant |
Ayme-Gripp syndrome [RCV000149904]|not provided [RCV000254853] |
Chr16:79599730 [GRCh38] Chr16:79633627 [GRCh37] Chr16:16q23.2 |
pathogenic |
NM_005360.5(MAF):c.176C>A (p.Pro59His) |
single nucleotide variant |
Ayme-Gripp syndrome [RCV000149905] |
Chr16:79599727 [GRCh38] Chr16:79633624 [GRCh37] Chr16:16q23.2 |
pathogenic |
NM_005360.5(MAF):c.176C>T (p.Pro59Leu) |
single nucleotide variant |
Ayme-Gripp syndrome [RCV000149906] |
Chr16:79599727 [GRCh38] Chr16:79633624 [GRCh37] Chr16:16q23.2 |
pathogenic |
NM_005360.5(MAF):c.185C>G (p.Thr62Arg) |
single nucleotide variant |
Ayme-Gripp syndrome [RCV000149907]|not provided [RCV002264911] |
Chr16:79599718 [GRCh38] Chr16:79633615 [GRCh37] Chr16:16q23.2 |
pathogenic |
NM_005360.5(MAF):c.206C>G (p.Pro69Arg) |
single nucleotide variant |
Ayme-Gripp syndrome [RCV000149908]|not provided [RCV000413144] |
Chr16:79599697 [GRCh38] Chr16:79633594 [GRCh37] Chr16:16q23.2 |
pathogenic|likely pathogenic |
GRCh38/hg38 16q23.1-23.2(chr16:78923731-79507803)x3 |
copy number gain |
See cases [RCV000138539] |
Chr16:78923731..79507803 [GRCh38] Chr16:78957628..79541700 [GRCh37] Chr16:77515129..78099201 [NCBI36] Chr16:16q23.1-23.2 |
likely pathogenic|uncertain significance |
NM_005360.5(MAF):c.819G>C (p.Glu273Asp) |
single nucleotide variant |
Developmental cataract [RCV000203389] |
Chr16:79599084 [GRCh38] Chr16:79632981 [GRCh37] Chr16:16q23.2 |
likely pathogenic |
NM_005360.5(MAF):c.915C>T (p.Cys305=) |
single nucleotide variant |
Developmental cataract [RCV000203395] |
Chr16:79598988 [GRCh38] Chr16:79632885 [GRCh37] Chr16:16q23.2 |
likely pathogenic |
NM_005360.5(MAF):c.880C>T (p.Arg294Trp) |
single nucleotide variant |
Developmental cataract [RCV000203408] |
Chr16:79599023 [GRCh38] Chr16:79632920 [GRCh37] Chr16:16q23.2 |
likely pathogenic |
NM_016373.4(WWOX):c.1240G>A (p.Gly414Ser) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV000545336]|Inborn genetic diseases [RCV004965532]|not provided [RCV000519792] |
Chr16:79211791 [GRCh38] Chr16:79245688 [GRCh37] Chr16:16q23.2 |
likely benign|uncertain significance |
GRCh37/hg19 16q11.2-24.3(chr16:46615804-90142285)x1 |
copy number loss |
Breast ductal adenocarcinoma [RCV000207138] |
Chr16:46615804..90142285 [GRCh37] Chr16:16q11.2-24.3 |
uncertain significance |
NM_016373.4(WWOX):c.1141C>T (p.Arg381Cys) |
single nucleotide variant |
Autosomal recessive spinocerebellar ataxia 12 [RCV002243897]|Developmental and epileptic encephalopathy, 1 [RCV001081219]|Developmental and epileptic encephalopathy, 28 [RCV002243898]|not provided [RCV000224270]|not specified [RCV000437104] |
Chr16:79211692 [GRCh38] Chr16:79245589 [GRCh37] Chr16:16q23.2 |
benign|likely benign |
NM_016373.4(WWOX):c.1238C>A (p.Ser413Tyr) |
single nucleotide variant |
Autosomal recessive spinocerebellar ataxia 12 [RCV002243908]|Developmental and epileptic encephalopathy, 1 [RCV000234375]|Developmental and epileptic encephalopathy, 28 [RCV002243909]|not provided [RCV000714206]|not specified [RCV000427849] |
Chr16:79211789 [GRCh38] Chr16:79245686 [GRCh37] Chr16:16q23.2 |
likely pathogenic|benign |
NM_016373.4(WWOX):c.1114G>C (p.Gly372Arg) |
single nucleotide variant |
Autosomal recessive spinocerebellar ataxia 12 [RCV000087048]|not provided [RCV001091765] |
Chr16:79211665 [GRCh38] Chr16:79245562 [GRCh37] Chr16:16q23.2 |
pathogenic |
NM_005360.5(MAF):c.435_440del (p.143GA[2]) |
deletion |
Cataract 21 multiple types [RCV001367521] |
Chr16:79599463..79599468 [GRCh38] Chr16:79633360..79633365 [GRCh37] Chr16:16q23.2 |
likely benign|uncertain significance |
NM_005360.5(MAF):c.715G>A (p.Ala239Thr) |
single nucleotide variant |
Cataract 21 multiple types [RCV000540203]|not provided [RCV001552436] |
Chr16:79599188 [GRCh38] Chr16:79633085 [GRCh37] Chr16:16q23.2 |
benign|likely benign|uncertain significance |
NM_005360.5(MAF):c.-30GGC[5] |
microsatellite |
not provided [RCV001660284]|not specified [RCV000249646] |
Chr16:79599909..79599917 [GRCh38] Chr16:79633806..79633814 [GRCh37] Chr16:16q23.2 |
benign |
NM_005360.5(MAF):c.702A>C (p.Gly234=) |
single nucleotide variant |
Cataract 21 multiple types [RCV000878139]|Inborn genetic diseases [RCV004639199]|not provided [RCV001640537]|not specified [RCV000244986] |
Chr16:79599201 [GRCh38] Chr16:79633098 [GRCh37] Chr16:16q23.2 |
benign|likely benign |
NM_016373.4(WWOX):c.1057-14T>C |
single nucleotide variant |
Autosomal recessive spinocerebellar ataxia 12 [RCV002244634]|Developmental and epileptic encephalopathy, 1 [RCV001515358]|Developmental and epileptic encephalopathy, 28 [RCV002244635]|not provided [RCV004709463]|not specified [RCV000247690] |
Chr16:79211594 [GRCh38] Chr16:79245491 [GRCh37] Chr16:16q23.2 |
benign |
NM_016373.4(WWOX):c.*200GGGCT[1] |
microsatellite |
not provided [RCV001591177]|not specified [RCV000520526] |
Chr16:79211996..79212000 [GRCh38] Chr16:79245893..79245897 [GRCh37] Chr16:16q23.2 |
benign|likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_016373.4(WWOX):c.1207_1208del (p.Arg403fs) |
microsatellite |
not provided [RCV000521559] |
Chr16:79211755..79211756 [GRCh38] Chr16:79245652..79245653 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1204G>A (p.Glu402Lys) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV000552320]|Inborn genetic diseases [RCV004023549]|not provided [RCV000523943] |
Chr16:79211755 [GRCh38] Chr16:79245652 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.820C>G (p.Leu274Val) |
single nucleotide variant |
not provided [RCV002292930] |
Chr16:79599083 [GRCh38] Chr16:79632980 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1204G>T (p.Glu402Ter) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 28 [RCV003338633]|not provided [RCV000520674] |
Chr16:79211755 [GRCh38] Chr16:79245652 [GRCh37] Chr16:16q23.2 |
likely pathogenic|conflicting interpretations of pathogenicity|uncertain significance |
NM_005360.5(MAF):c.208dup (p.Ser70fs) |
duplication |
not provided [RCV000521239] |
Chr16:79599694..79599695 [GRCh38] Chr16:79633591..79633592 [GRCh37] Chr16:16q23.2 |
pathogenic |
NM_005360.5(MAF):c.188C>G (p.Pro63Arg) |
single nucleotide variant |
Developmental cataract [RCV000415117] |
Chr16:79599715 [GRCh38] Chr16:79633612 [GRCh37] Chr16:16q23.2 |
likely pathogenic |
NM_016373.4(WWOX):c.1231_1233del (p.Ser411del) |
deletion |
Autosomal recessive spinocerebellar ataxia 12 [RCV000415436]|Developmental and epileptic encephalopathy, 1 [RCV000695511] |
Chr16:79211780..79211782 [GRCh38] Chr16:79245677..79245679 [GRCh37] Chr16:16q23.2 |
uncertain significance |
GRCh37/hg19 16q11.2-24.3(chr16:46464488-90155062)x3 |
copy number gain |
See cases [RCV000446110] |
Chr16:46464488..90155062 [GRCh37] Chr16:16q11.2-24.3 |
pathogenic |
NM_016373.4(WWOX):c.1197G>A (p.Ala399=) |
single nucleotide variant |
Autosomal recessive spinocerebellar ataxia 12 [RCV002244902]|Developmental and epileptic encephalopathy, 1 [RCV001082606]|Developmental and epileptic encephalopathy, 28 [RCV002244903]|not provided [RCV000714205] |
Chr16:79211748 [GRCh38] Chr16:79245645 [GRCh37] Chr16:16q23.2 |
benign|likely benign |
NM_016373.4(WWOX):c.1146C>T (p.Cys382=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV000695560]|not provided [RCV000427908]|not specified [RCV001821181] |
Chr16:79211697 [GRCh38] Chr16:79245594 [GRCh37] Chr16:16q23.2 |
likely benign|uncertain significance |
NM_016373.4(WWOX):c.1179G>A (p.Thr393=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV000468158]|not specified [RCV000438732] |
Chr16:79211730 [GRCh38] Chr16:79245627 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.544CAC[5] (p.His187del) |
microsatellite |
MAF-related disorder [RCV003912595]|not provided [RCV000423794] |
Chr16:79599342..79599344 [GRCh38] Chr16:79633239..79633241 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1077C>T (p.Thr359=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001457219]|not specified [RCV000432443] |
Chr16:79211628 [GRCh38] Chr16:79245525 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1066G>A (p.Ala356Thr) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV000553103]|not provided [RCV000429731] |
Chr16:79211617 [GRCh38] Chr16:79245514 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1134C>T (p.Asn378=) |
single nucleotide variant |
Autosomal recessive spinocerebellar ataxia 12 [RCV002244894]|Developmental and epileptic encephalopathy, 1 [RCV000526819]|Developmental and epileptic encephalopathy, 28 [RCV002244895]|Malignant tumor of esophagus [RCV000602793]|Malignant tumor of esophagus [RCV002502527]|not provided [RCV003333985]|not specified [RCV000443836] |
Chr16:79211685 [GRCh38] Chr16:79245582 [GRCh37] Chr16:16q23.2 |
benign|likely benign|conflicting interpretations of pathogenicity |
NM_016373.4(WWOX):c.*3G>T |
single nucleotide variant |
Autosomal recessive spinocerebellar ataxia 12 [RCV002244891]|Developmental and epileptic encephalopathy, 28 [RCV002244892]|not provided [RCV000714203]|not specified [RCV000422776] |
Chr16:79211799 [GRCh38] Chr16:79245696 [GRCh37] Chr16:16q23.2 |
benign |
NM_016373.4(WWOX):c.*1G>C |
single nucleotide variant |
not specified [RCV000426348] |
Chr16:79211797 [GRCh38] Chr16:79245694 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.*15G>A |
single nucleotide variant |
not specified [RCV000440538] |
Chr16:79211811 [GRCh38] Chr16:79245708 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1203C>T (p.Ser401=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV000466131]|not provided [RCV001720175]|not specified [RCV001821177] |
Chr16:79211754 [GRCh38] Chr16:79245651 [GRCh37] Chr16:16q23.2 |
likely benign|conflicting interpretations of pathogenicity |
NM_016373.4(WWOX):c.*18T>C |
single nucleotide variant |
not specified [RCV000430659] |
Chr16:79211814 [GRCh38] Chr16:79245711 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1115G>A (p.Gly372Glu) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV000650195]|not provided [RCV000480798] |
Chr16:79211666 [GRCh38] Chr16:79245563 [GRCh37] Chr16:16q23.2 |
pathogenic|uncertain significance |
NM_016373.4(WWOX):c.1158A>G (p.Pro386=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001463482] |
Chr16:79211709 [GRCh38] Chr16:79245606 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1057-16del |
deletion |
not specified [RCV000484470] |
Chr16:79211592 [GRCh38] Chr16:79245489 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1170C>A (p.Ser390Arg) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV000467962] |
Chr16:79211721 [GRCh38] Chr16:79245618 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1142G>A (p.Arg381His) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV000460537]|Intellectual disability [RCV001252635]|WWOX-related disorder [RCV003960033]|not provided [RCV001569721] |
Chr16:79211693 [GRCh38] Chr16:79245590 [GRCh37] Chr16:16q23.2 |
likely benign|uncertain significance |
NM_016373.4(WWOX):c.1179_1210del (p.Ala394fs) |
deletion |
Developmental and epileptic encephalopathy, 1 [RCV000464767] |
Chr16:79211729..79211760 [GRCh38] Chr16:79245626..79245657 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1162G>C (p.Ala388Pro) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV000476559] |
Chr16:79211713 [GRCh38] Chr16:79245610 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1178C>T (p.Thr393Met) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001080806]|Inborn genetic diseases [RCV002523319]|not provided [RCV000466359] |
Chr16:79211729 [GRCh38] Chr16:79245626 [GRCh37] Chr16:16q23.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
GRCh37/hg19 16p13.2-q24.3(chr16:9273328-89548493)x3 |
copy number gain |
See cases [RCV000511622] |
Chr16:9273328..89548493 [GRCh37] Chr16:16p13.2-q24.3 |
uncertain significance |
GRCh37/hg19 16q11.2-24.3(chr16:46497599-90354753)x1 |
copy number loss |
Poly (ADP-Ribose) polymerase inhibitor response [RCV000626429] |
Chr16:46497599..90354753 [GRCh37] Chr16:16q11.2-24.3 |
drug response |
GRCh37/hg19 16p13.3-q24.3(chr16:85881-90155062) |
copy number gain |
See cases [RCV000511296] |
Chr16:85881..90155062 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
NM_016373.4(WWOX):c.1228G>T (p.Gly410Cys) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV000650211]|WWOX-related disorder [RCV004752967]|not provided [RCV001722560]|not specified [RCV001815005] |
Chr16:79211779 [GRCh38] Chr16:79245676 [GRCh37] Chr16:16q23.2 |
benign|likely benign|uncertain significance |
GRCh37/hg19 16p13.3-q24.3(chr16:85881-90155062)x3 |
copy number gain |
See cases [RCV000512138] |
Chr16:85881..90155062 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
NM_005360.5(MAF):c.170C>T (p.Ser57Phe) |
single nucleotide variant |
Inborn genetic diseases [RCV000624111]|not provided [RCV004719906] |
Chr16:79599733 [GRCh38] Chr16:79633630 [GRCh37] Chr16:16q23.2 |
likely pathogenic|uncertain significance |
NM_016373.4(WWOX):c.1143C>T (p.Arg381=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001492624]|not provided [RCV001698038] |
Chr16:79211694 [GRCh38] Chr16:79245591 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1078G>A (p.Val360Met) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV000650198]|Inborn genetic diseases [RCV003162977]|not provided [RCV004692032] |
Chr16:79211629 [GRCh38] Chr16:79245526 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1057-18_1057-17dup |
duplication |
Developmental and epileptic encephalopathy, 1 [RCV002064037]|not specified [RCV000616759] |
Chr16:79211588..79211589 [GRCh38] Chr16:79245485..79245486 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1197G>T (p.Ala399=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001458527]|not specified [RCV000608413] |
Chr16:79211748 [GRCh38] Chr16:79245645 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.293C>A (p.Pro98Gln) |
single nucleotide variant |
Cataract 21 multiple types [RCV000652086] |
Chr16:79599610 [GRCh38] Chr16:79633507 [GRCh37] Chr16:16q23.2 |
benign|uncertain significance |
GRCh37/hg19 16q13-24.3(chr16:57051473-89797669)x3 |
copy number gain |
See cases [RCV000512511] |
Chr16:57051473..89797669 [GRCh37] Chr16:16q13-24.3 |
pathogenic |
NM_016373.4(WWOX):c.1139G>A (p.Cys380Tyr) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV000686392]|Inborn genetic diseases [RCV004026025]|not provided [RCV000658209] |
Chr16:79211690 [GRCh38] Chr16:79245587 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.678CGG[10] (p.Gly237_Gly238dup) |
microsatellite |
Cataract 21 multiple types [RCV000699211]|MAF-related disorder [RCV003907951]|not provided [RCV001585643] |
Chr16:79599201..79599202 [GRCh38] Chr16:79633098..79633099 [GRCh37] Chr16:16q23.2 |
likely benign|uncertain significance |
NM_016373.4(WWOX):c.1057-3C>T |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV000692946] |
Chr16:79211605 [GRCh38] Chr16:79245502 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1223G>A (p.Arg408Gln) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV000691014]|Inborn genetic diseases [RCV004025067]|Malignant tumor of esophagus [RCV002477554]|not provided [RCV004692111] |
Chr16:79211774 [GRCh38] Chr16:79245671 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1072A>C (p.Thr358Pro) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV000706593] |
Chr16:79211623 [GRCh38] Chr16:79245520 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1170C>G (p.Ser390Arg) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV000688829] |
Chr16:79211721 [GRCh38] Chr16:79245618 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NC_000016.10:g.(?_79211588)_(79211816_?)del |
deletion |
Developmental and epileptic encephalopathy, 1 [RCV000814620] |
Chr16:79211588..79211816 [GRCh38] Chr16:79245485..79245713 [GRCh37] Chr16:16q23.2 |
pathogenic |
NM_005360.5(MAF):c.1118+176AC[13] |
microsatellite |
not provided [RCV001537609] |
Chr16:79598582..79598583 [GRCh38] Chr16:79632479..79632480 [GRCh37] Chr16:16q23.2 |
benign |
GRCh37/hg19 16p13.3-q24.3(chr16:88165-90163275)x3 |
copy number gain |
not provided [RCV000738917] |
Chr16:88165..90163275 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
NM_016373.4(WWOX):c.*93A>G |
single nucleotide variant |
not provided [RCV001540782] |
Chr16:79211889 [GRCh38] Chr16:79245786 [GRCh37] Chr16:16q23.2 |
benign |
NC_000016.10:g.(?_79103200)_(79402155_?)del |
deletion |
Schizophrenia [RCV000754197] |
Chr16:79103200..79402155 [GRCh38] Chr16:16q23.1-23.2 |
likely pathogenic |
NC_000016.10:g.79601052T>C |
single nucleotide variant |
not provided [RCV001666428] |
Chr16:79601052 [GRCh38] Chr16:79634949 [GRCh37] Chr16:16q23.2 |
benign |
NM_005360.5(MAF):c.1028C>T (p.Ala343Val) |
single nucleotide variant |
Cataract 21 multiple types [RCV001515883] |
Chr16:79598875 [GRCh38] Chr16:79632772 [GRCh37] Chr16:16q23.2 |
benign |
NM_016373.4(WWOX):c.1191G>C (p.Leu397=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV002540968] |
Chr16:79211742 [GRCh38] Chr16:79245639 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1107G>A (p.Glu369=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001504073] |
Chr16:79211658 [GRCh38] Chr16:79245555 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1132_1133delinsTG (p.Asn378Cys) |
indel |
Developmental and epileptic encephalopathy, 1 [RCV001040848] |
Chr16:79211683..79211684 [GRCh38] Chr16:79245580..79245581 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1150C>T (p.Pro384Ser) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV000819051] |
Chr16:79211701 [GRCh38] Chr16:79245598 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1057-292C>T |
single nucleotide variant |
not provided [RCV000829037] |
Chr16:79211316 [GRCh38] Chr16:79245213 [GRCh37] Chr16:16q23.2 |
benign |
NM_005360.5(MAF):c.881G>A (p.Arg294Gln) |
single nucleotide variant |
Cataract 21 multiple types [RCV000822360] |
Chr16:79599022 [GRCh38] Chr16:79632919 [GRCh37] Chr16:16q23.2 |
pathogenic |
NM_016373.4(WWOX):c.1057-266T>C |
single nucleotide variant |
not provided [RCV000827801] |
Chr16:79211342 [GRCh38] Chr16:79245239 [GRCh37] Chr16:16q23.2 |
benign |
NM_016373.4(WWOX):c.1182_1183dup (p.Arg395fs) |
duplication |
not provided [RCV001091766] |
Chr16:79211731..79211732 [GRCh38] Chr16:79245628..79245629 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1057-142C>G |
single nucleotide variant |
not provided [RCV000837068] |
Chr16:79211466 [GRCh38] Chr16:79245363 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1184G>A (p.Arg395Gln) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV000799565]|Inborn genetic diseases [RCV004962808]|not provided [RCV001759520] |
Chr16:79211735 [GRCh38] Chr16:79245632 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1125C>T (p.Tyr375=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001476915]|WWOX-related disorder [RCV003970610] |
Chr16:79211676 [GRCh38] Chr16:79245573 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1057-40T>C |
single nucleotide variant |
Autosomal recessive spinocerebellar ataxia 12 [RCV002245701]|Developmental and epileptic encephalopathy, 28 [RCV002245702]|not provided [RCV000830038]|not specified [RCV004594168] |
Chr16:79211568 [GRCh38] Chr16:79245465 [GRCh37] Chr16:16q23.2 |
benign |
NM_016373.4(WWOX):c.1110T>A (p.Gly370=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001393621] |
Chr16:79211661 [GRCh38] Chr16:79245558 [GRCh37] Chr16:16q23.2 |
likely benign |
GRCh37/hg19 16q21-24.3(chr16:61524229-90155062)x3 |
copy number gain |
not provided [RCV001249359] |
Chr16:61524229..90155062 [GRCh37] Chr16:16q21-24.3 |
not provided |
NM_005360.5(MAF):c.916C>G (p.Arg306Gly) |
single nucleotide variant |
Cataract 21 multiple types [RCV001224384]|Inborn genetic diseases [RCV004639507] |
Chr16:79598987 [GRCh38] Chr16:79632884 [GRCh37] Chr16:16q23.2 |
pathogenic|likely pathogenic|uncertain significance |
NM_005360.5(MAF):c.905C>A (p.Ala302Asp) |
single nucleotide variant |
Cataract 21 multiple types [RCV001230059] |
Chr16:79598998 [GRCh38] Chr16:79632895 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.716_726dup (p.Gly243fs) |
microsatellite |
not provided [RCV004776719] |
Chr16:79599176..79599177 [GRCh38] Chr16:79633073..79633074 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1185G>C (p.Arg395=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV002569049]|not provided [RCV001570577] |
Chr16:79211736 [GRCh38] Chr16:79245633 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.743C>A (p.Pro248Gln) |
single nucleotide variant |
Ayme-Gripp syndrome [RCV001542409] |
Chr16:79599160 [GRCh38] Chr16:79633057 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NC_000016.10:g.79600738A>G |
single nucleotide variant |
not provided [RCV001555106] |
Chr16:79600738 [GRCh38] Chr16:79634635 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.*33G>A |
single nucleotide variant |
not provided [RCV001591620] |
Chr16:79211829 [GRCh38] Chr16:79245726 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.1118+176AC[16] |
microsatellite |
not provided [RCV001685197] |
Chr16:79598581..79598582 [GRCh38] Chr16:79632478..79632479 [GRCh37] Chr16:16q23.2 |
benign |
NM_005360.5(MAF):c.*32del |
deletion |
not provided [RCV001639278] |
Chr16:79594428 [GRCh38] Chr16:79628325 [GRCh37] Chr16:16q23.2 |
benign |
NM_005360.5(MAF):c.1119-88_1119-87del |
deletion |
not provided [RCV001707339] |
Chr16:79594640..79594641 [GRCh38] Chr16:79628537..79628538 [GRCh37] Chr16:16q23.2 |
benign |
NM_005360.5(MAF):c.1119-87del |
deletion |
not provided [RCV001651819] |
Chr16:79594640 [GRCh38] Chr16:79628537 [GRCh37] Chr16:16q23.2 |
benign |
NM_005360.5(MAF):c.696C>A (p.Gly232=) |
single nucleotide variant |
Cataract 21 multiple types [RCV001506630]|not provided [RCV000951678] |
Chr16:79599207 [GRCh38] Chr16:79633104 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1165C>G (p.Gln389Glu) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001243203] |
Chr16:79211716 [GRCh38] Chr16:79245613 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1195G>A (p.Ala399Thr) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001247966]|Inborn genetic diseases [RCV004963303] |
Chr16:79211746 [GRCh38] Chr16:79245643 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1110_1119del (p.Leu371fs) |
deletion |
Developmental and epileptic encephalopathy, 1 [RCV001232173]|not provided [RCV003490145] |
Chr16:79211655..79211664 [GRCh38] Chr16:79245552..79245561 [GRCh37] Chr16:16q23.2 |
pathogenic|likely pathogenic|uncertain significance |
NM_016373.4(WWOX):c.1219_1220inv (p.Glu407Ser) |
inversion |
Developmental and epileptic encephalopathy, 1 [RCV001243439] |
Chr16:79211770..79211771 [GRCh38] Chr16:79245667..79245668 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1157C>T (p.Pro386Leu) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001227598] |
Chr16:79211708 [GRCh38] Chr16:79245605 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1145G>A (p.Cys382Tyr) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001216959]|Inborn genetic diseases [RCV003259162] |
Chr16:79211696 [GRCh38] Chr16:79245593 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1126T>C (p.Phe376Leu) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001237882] |
Chr16:79211677 [GRCh38] Chr16:79245574 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.*263C>G |
single nucleotide variant |
not provided [RCV001620666]|not specified [RCV004594406] |
Chr16:79212059 [GRCh38] Chr16:79245956 [GRCh37] Chr16:16q23.2 |
benign |
NM_016373.4(WWOX):c.*97A>G |
single nucleotide variant |
not provided [RCV001574718] |
Chr16:79211893 [GRCh38] Chr16:79245790 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.1118+183_1118+184insCACG |
insertion |
not provided [RCV001567676] |
Chr16:79598601..79598602 [GRCh38] Chr16:79632498..79632499 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.1118+176AC[12] |
microsatellite |
not provided [RCV001559681] |
Chr16:79598582..79598585 [GRCh38] Chr16:79632479..79632482 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.1118+217C>T |
single nucleotide variant |
not provided [RCV001717866] |
Chr16:79598568 [GRCh38] Chr16:79632465 [GRCh37] Chr16:16q23.2 |
benign |
NM_005360.5(MAF):c.-759C>T |
single nucleotide variant |
not provided [RCV001560161] |
Chr16:79600661 [GRCh38] Chr16:79634558 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.*219G>C |
single nucleotide variant |
not provided [RCV001556009] |
Chr16:79594241 [GRCh38] Chr16:79628138 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.224C>T (p.Ala75Val) |
single nucleotide variant |
Ayme-Gripp syndrome [RCV004799480] |
Chr16:79599679 [GRCh38] Chr16:79633576 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.1119-169dup |
duplication |
not provided [RCV001695563] |
Chr16:79594712..79594713 [GRCh38] Chr16:79628609..79628610 [GRCh37] Chr16:16q23.2 |
benign |
NM_016373.4(WWOX):c.*72C>T |
single nucleotide variant |
not provided [RCV001719172] |
Chr16:79211868 [GRCh38] Chr16:79245765 [GRCh37] Chr16:16q23.2 |
benign |
NM_016373.4(WWOX):c.*237G>C |
single nucleotide variant |
not provided [RCV001688158] |
Chr16:79212033 [GRCh38] Chr16:79245930 [GRCh37] Chr16:16q23.2 |
benign |
NM_005360.5(MAF):c.*176A>G |
single nucleotide variant |
not provided [RCV001672211] |
Chr16:79594284 [GRCh38] Chr16:79628181 [GRCh37] Chr16:16q23.2 |
benign |
NM_005360.5(MAF):c.699C>A (p.Gly233=) |
single nucleotide variant |
not provided [RCV001581244] |
Chr16:79599204 [GRCh38] Chr16:79633101 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.-152C>T |
single nucleotide variant |
not provided [RCV001676588] |
Chr16:79600054 [GRCh38] Chr16:79633951 [GRCh37] Chr16:16q23.2 |
benign |
NM_016373.4(WWOX):c.*127G>T |
single nucleotide variant |
not provided [RCV001656474]|not specified [RCV004594448] |
Chr16:79211923 [GRCh38] Chr16:79245820 [GRCh37] Chr16:16q23.2 |
benign |
NM_005360.5(MAF):c.-88C>T |
single nucleotide variant |
not provided [RCV001587190] |
Chr16:79599990 [GRCh38] Chr16:79633887 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.*33G>C |
single nucleotide variant |
not provided [RCV001171779] |
Chr16:79211829 [GRCh38] Chr16:79245726 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.*268T>C |
single nucleotide variant |
not provided [RCV001648996]|not specified [RCV004594439] |
Chr16:79212064 [GRCh38] Chr16:79245961 [GRCh37] Chr16:16q23.2 |
benign |
NM_005360.5(MAF):c.1118+67T>C |
single nucleotide variant |
not provided [RCV001588249] |
Chr16:79598718 [GRCh38] Chr16:79632615 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.180G>T (p.Met60Ile) |
single nucleotide variant |
not provided [RCV001586602] |
Chr16:79599723 [GRCh38] Chr16:79633620 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.-780T>G |
single nucleotide variant |
not provided [RCV001650411] |
Chr16:79600682 [GRCh38] Chr16:79634579 [GRCh37] Chr16:16q23.2 |
benign |
NM_005360.5(MAF):c.1110G>C (p.Glu370Asp) |
single nucleotide variant |
Cataract 21 multiple types [RCV001071892] |
Chr16:79598793 [GRCh38] Chr16:79632690 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.*184_*188dup |
duplication |
not provided [RCV001610104] |
Chr16:79211976..79211977 [GRCh38] Chr16:79245873..79245874 [GRCh37] Chr16:16q23.2 |
benign |
NM_016373.4(WWOX):c.*211G>A |
single nucleotide variant |
not provided [RCV001649308] |
Chr16:79212007 [GRCh38] Chr16:79245904 [GRCh37] Chr16:16q23.2 |
benign |
NM_016373.4(WWOX):c.1151C>G (p.Pro384Arg) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001048983] |
Chr16:79211702 [GRCh38] Chr16:79245599 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.914G>A (p.Cys305Tyr) |
single nucleotide variant |
Cataract 21 multiple types [RCV001235674] |
Chr16:79598989 [GRCh38] Chr16:79632886 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1218A>C (p.Gln406His) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001218845] |
Chr16:79211769 [GRCh38] Chr16:79245666 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1240_*36del (p.Gly414_Ter415del) |
deletion |
Developmental and epileptic encephalopathy, 1 [RCV001035387] |
Chr16:79211789..79211830 [GRCh38] Chr16:79245686..79245727 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.941A>C (p.His314Pro) |
single nucleotide variant |
Cataract 21 multiple types [RCV001199226] |
Chr16:79598962 [GRCh38] Chr16:79632859 [GRCh37] Chr16:16q23.2 |
likely pathogenic |
NM_016373.4(WWOX):c.1087G>C (p.Ala363Pro) |
single nucleotide variant |
not provided [RCV001091764] |
Chr16:79211638 [GRCh38] Chr16:79245535 [GRCh37] Chr16:16q23.2 |
uncertain significance |
GRCh37/hg19 16q23.1-23.2(chr16:78426151-81049683)x3 |
copy number gain |
not provided [RCV001006823] |
Chr16:78426151..81049683 [GRCh37] Chr16:16q23.1-23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1216C>T (p.Gln406Ter) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001040374] |
Chr16:79211767 [GRCh38] Chr16:79245664 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1172A>G (p.Glu391Gly) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001040398]|Inborn genetic diseases [RCV004678900]|not provided [RCV001585939]|not specified [RCV004782630] |
Chr16:79211723 [GRCh38] Chr16:79245620 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1172_*15del (p.Glu391fs) |
deletion |
not provided [RCV001200600] |
Chr16:79211712..79211800 [GRCh38] Chr16:79245609..79245697 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.887T>C (p.Leu296Pro) |
single nucleotide variant |
Inborn genetic diseases [RCV001266373] |
Chr16:79599016 [GRCh38] Chr16:79632913 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.1119-179C>T |
single nucleotide variant |
not provided [RCV001548619] |
Chr16:79594732 [GRCh38] Chr16:79628629 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.60A>T (p.Glu20Asp) |
single nucleotide variant |
Ayme-Gripp syndrome [RCV001330055] |
Chr16:79599843 [GRCh38] Chr16:79633740 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1085G>A (p.Cys362Tyr) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001351418]|not provided [RCV001586144]|not specified [RCV004526115] |
Chr16:79211636 [GRCh38] Chr16:79245533 [GRCh37] Chr16:16q23.2 |
likely pathogenic|uncertain significance |
NM_016373.4(WWOX):c.1204G>C (p.Glu402Gln) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001302038]|Inborn genetic diseases [RCV002543095] |
Chr16:79211755 [GRCh38] Chr16:79245652 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1113G>T (p.Leu371=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001422204] |
Chr16:79211664 [GRCh38] Chr16:79245561 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.*15G>T |
single nucleotide variant |
Developmental and epileptic encephalopathy, 28 [RCV001335815]|not provided [RCV003456491]|not specified [RCV002246312] |
Chr16:79211811 [GRCh38] Chr16:79245708 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1160A>G (p.Glu387Gly) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001323944]|Inborn genetic diseases [RCV004035117] |
Chr16:79211711 [GRCh38] Chr16:79245608 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1206G>C (p.Glu402Asp) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001347310] |
Chr16:79211757 [GRCh38] Chr16:79245654 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1108G>A (p.Gly370Ser) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001327899] |
Chr16:79211659 [GRCh38] Chr16:79245556 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.*44G>T |
single nucleotide variant |
not provided [RCV001311451] |
Chr16:79211840 [GRCh38] Chr16:79245737 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1057C>A (p.Gln353Lys) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001295210] |
Chr16:79211608 [GRCh38] Chr16:79245505 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1084T>C (p.Cys362Arg) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001352381] |
Chr16:79211635 [GRCh38] Chr16:79245532 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1086T>C (p.Cys362=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001414125] |
Chr16:79211637 [GRCh38] Chr16:79245534 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1063G>A (p.Gly355Arg) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001315818] |
Chr16:79211614 [GRCh38] Chr16:79245511 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1134C>G (p.Asn378Lys) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001359149] |
Chr16:79211685 [GRCh38] Chr16:79245582 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.649G>A (p.Gly217Ser) |
single nucleotide variant |
Cataract 21 multiple types [RCV001408192]|Inborn genetic diseases [RCV004038036] |
Chr16:79599254 [GRCh38] Chr16:79633151 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.*293G>A |
single nucleotide variant |
not provided [RCV001593558] |
Chr16:79212089 [GRCh38] Chr16:79245986 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.433G>A (p.Gly145Ser) |
single nucleotide variant |
Cataract 21 multiple types [RCV003771801]|MAF-related disorder [RCV003941041]|not provided [RCV001590868] |
Chr16:79599470 [GRCh38] Chr16:79633367 [GRCh37] Chr16:16q23.2 |
benign|likely benign|uncertain significance |
NM_005360.5(MAF):c.528C>G (p.Gly176=) |
single nucleotide variant |
Cataract 21 multiple types [RCV001498047] |
Chr16:79599375 [GRCh38] Chr16:79633272 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.1179G>A (p.Gln393=) |
single nucleotide variant |
Cataract 21 multiple types [RCV001518860]|MAF-related disorder [RCV003921141]|not provided [RCV003416381] |
Chr16:79594493 [GRCh38] Chr16:79628390 [GRCh37] Chr16:16q23.2 |
benign|likely benign |
NM_005360.5(MAF):c.678CGG[7] (p.Gly238del) |
microsatellite |
Cataract 21 multiple types [RCV001482781]|not provided [RCV001565674] |
Chr16:79599202..79599204 [GRCh38] Chr16:79633099..79633101 [GRCh37] Chr16:16q23.2 |
likely benign|uncertain significance |
NM_016373.4(WWOX):c.1223G>T (p.Arg408Leu) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV003093941]|Developmental and epileptic encephalopathy, 28 [RCV002244208]|Inborn genetic diseases [RCV003250475] |
Chr16:79211774 [GRCh38] Chr16:79245671 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.1037A>G (p.Glu346Gly) |
single nucleotide variant |
not provided [RCV001754975] |
Chr16:79598866 [GRCh38] Chr16:79632763 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.412C>A (p.Leu138Met) |
single nucleotide variant |
Cataract 21 multiple types [RCV002273193]|Cataract 21 multiple types [RCV003096150]|not provided [RCV004809804] |
Chr16:79599491 [GRCh38] Chr16:79633388 [GRCh37] Chr16:16q23.2 |
likely benign|uncertain significance |
NM_016373.4(WWOX):c.1171G>T (p.Glu391Ter) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 28 [RCV001800162]|Neurodevelopmental delay [RCV002274210] |
Chr16:79211722 [GRCh38] Chr16:79245619 [GRCh37] Chr16:16q23.2 |
pathogenic |
NM_005360.5(MAF):c.520C>G (p.Gln174Glu) |
single nucleotide variant |
not provided [RCV001752406] |
Chr16:79599383 [GRCh38] Chr16:79633280 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.460G>A (p.Gly154Ser) |
single nucleotide variant |
Cataract 21 multiple types [RCV002074020]|Inborn genetic diseases [RCV002540523]|MAF-related disorder [RCV003968537]|not provided [RCV001771183] |
Chr16:79599443 [GRCh38] Chr16:79633340 [GRCh37] Chr16:16q23.2 |
likely benign|conflicting interpretations of pathogenicity|uncertain significance |
NM_005360.5(MAF):c.898G>A (p.Gly300Ser) |
single nucleotide variant |
not provided [RCV001761190] |
Chr16:79599005 [GRCh38] Chr16:79632902 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1152C>G (p.Pro384=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV005225512]|not specified [RCV001817287] |
Chr16:79211703 [GRCh38] Chr16:79245600 [GRCh37] Chr16:16q23.2 |
likely benign|uncertain significance |
NM_016373.4(WWOX):c.1141C>G (p.Arg381Gly) |
single nucleotide variant |
not provided [RCV001757749] |
Chr16:79211692 [GRCh38] Chr16:79245589 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1178C>A (p.Thr393Lys) |
single nucleotide variant |
not specified [RCV001819295] |
Chr16:79211729 [GRCh38] Chr16:79245626 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1063G>C (p.Gly355Arg) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 28 [RCV001814616] |
Chr16:79211614 [GRCh38] Chr16:79245511 [GRCh37] Chr16:16q23.2 |
likely pathogenic |
NM_016373.4(WWOX):c.1114G>A (p.Gly372Arg) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001891133] |
Chr16:79211665 [GRCh38] Chr16:79245562 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1244A>C (p.Ter415Ser) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001986987] |
Chr16:79211795 [GRCh38] Chr16:79245692 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1057C>T (p.Gln353Ter) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001895441] |
Chr16:79211608 [GRCh38] Chr16:79245505 [GRCh37] Chr16:16q23.2 |
pathogenic |
NM_005360.5(MAF):c.797T>G (p.Leu266Arg) |
single nucleotide variant |
Cataract 21 multiple types [RCV001964365] |
Chr16:79599106 [GRCh38] Chr16:79633003 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1226T>C (p.Leu409Pro) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001945742] |
Chr16:79211777 [GRCh38] Chr16:79245674 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.864G>A (p.Arg288=) |
single nucleotide variant |
Cataract 21 multiple types [RCV005213612]|not specified [RCV001844620] |
Chr16:79599039 [GRCh38] Chr16:79632936 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1057-9_1057-6dup |
duplication |
Developmental and epileptic encephalopathy, 1 [RCV001926804] |
Chr16:79211598..79211599 [GRCh38] Chr16:79245495..79245496 [GRCh37] Chr16:16q23.2 |
likely benign|uncertain significance |
GRCh37/hg19 16q23.1-23.2(chr16:77960664-81429258) |
copy number loss |
not specified [RCV002052545] |
Chr16:77960664..81429258 [GRCh37] Chr16:16q23.1-23.2 |
uncertain significance |
NM_005360.5(MAF):c.678CGG[4] (p.Gly235_Gly238del) |
microsatellite |
Cataract 21 multiple types [RCV001948580] |
Chr16:79599202..79599213 [GRCh38] Chr16:79633099..79633110 [GRCh37] Chr16:16q23.2 |
benign|uncertain significance |
NM_016373.4(WWOX):c.1142G>C (p.Arg381Pro) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV002007628] |
Chr16:79211693 [GRCh38] Chr16:79245590 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.678CGG[9] (p.Gly238dup) |
microsatellite |
Cataract 21 multiple types [RCV002041896]|Inborn genetic diseases [RCV002545408] |
Chr16:79599201..79599202 [GRCh38] Chr16:79633098..79633099 [GRCh37] Chr16:16q23.2 |
likely benign|uncertain significance |
NM_005360.5(MAF):c.163C>G (p.Leu55Val) |
single nucleotide variant |
not provided [RCV002052312] |
Chr16:79599740 [GRCh38] Chr16:79633637 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.1118+176AC[18] |
microsatellite |
not provided [RCV002034829] |
Chr16:79598581..79598582 [GRCh38] Chr16:79632478..79632479 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1175A>T (p.Glu392Val) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001941169] |
Chr16:79211726 [GRCh38] Chr16:79245623 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1109G>A (p.Gly370Asp) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001977223] |
Chr16:79211660 [GRCh38] Chr16:79245557 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1088C>G (p.Ala363Gly) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001962703] |
Chr16:79211639 [GRCh38] Chr16:79245536 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1073C>G (p.Thr358Ser) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001888825] |
Chr16:79211624 [GRCh38] Chr16:79245521 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1216C>G (p.Gln406Glu) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001876505] |
Chr16:79211767 [GRCh38] Chr16:79245664 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1183C>T (p.Arg395Trp) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV002027323]|Inborn genetic diseases [RCV002548874] |
Chr16:79211734 [GRCh38] Chr16:79245631 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1141C>A (p.Arg381Ser) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001990292] |
Chr16:79211692 [GRCh38] Chr16:79245589 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1205A>G (p.Glu402Gly) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV002050608] |
Chr16:79211756 [GRCh38] Chr16:79245653 [GRCh37] Chr16:16q23.2 |
uncertain significance |
Single allele |
deletion |
Normal pregnancy [RCV000161798] |
Chr16:79218427..79239785 [GRCh38] Chr16:79252324..79273682 [GRCh37] Chr16:16q23.2 |
not provided |
NC_000016.10:g.79336986A>G |
single nucleotide variant |
Lung cancer [RCV000100260] |
Chr16:79336986 [GRCh38] Chr16:79370883 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NC_000016.10:g.79358407C>T |
single nucleotide variant |
Lung cancer [RCV000100261] |
Chr16:79358407 [GRCh38] Chr16:79392304 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NC_000016.10:g.79442803T>C |
single nucleotide variant |
Lung cancer [RCV000100262] |
Chr16:79442803 [GRCh38] Chr16:79476700 [GRCh37] Chr16:16q23.2 |
uncertain significance |
GRCh37/hg19 16q23.1-24.3(chr16:74872514-90274440)x3 |
copy number gain |
See cases [RCV000240108] |
Chr16:74872514..90274440 [GRCh37] Chr16:16q23.1-24.3 |
pathogenic |
t(5;16)(p15.31;q23.1) |
translocation |
not provided [RCV000203391] |
Chr5:1..8180513 [GRCh37] Chr16:76935310..90354753 [GRCh37] Chr5:5p15.33-15.31 Chr16:16q23.1-24.3 |
likely pathogenic |
GRCh37/hg19 16q22.2-24.3(chr16:72107834-90142285)x1 |
copy number loss |
Breast ductal adenocarcinoma [RCV000207182] |
Chr16:72107834..90142285 [GRCh37] Chr16:16q22.2-24.3 |
uncertain significance |
Single allele |
complex |
Breast ductal adenocarcinoma [RCV000207314] |
Chr16:56368689..90141355 [GRCh37] Chr16:16q12.2-24.3 |
uncertain significance |
NM_016373.4(WWOX):c.1239C>T (p.Ser413=) |
single nucleotide variant |
Autosomal recessive spinocerebellar ataxia 12 [RCV002243910]|Developmental and epileptic encephalopathy, 1 [RCV001084018]|Developmental and epileptic encephalopathy, 28 [RCV002243911]|not provided [RCV000714207]|not specified [RCV000244339] |
Chr16:79211790 [GRCh38] Chr16:79245687 [GRCh37] Chr16:16q23.2 |
benign|likely benign |
NM_005360.5(MAF):c.-30GGC[7] |
microsatellite |
Ayme-Gripp syndrome [RCV001775745]|Cataract 21 multiple types [RCV001775744]|not provided [RCV001610662]|not specified [RCV000254425] |
Chr16:79599909..79599911 [GRCh38] Chr16:79633806..79633808 [GRCh37] Chr16:16q23.2 |
benign |
NM_005360.5(MAF):c.882G>A (p.Arg294=) |
single nucleotide variant |
Cataract 21 multiple types [RCV002058188]|not specified [RCV000248111] |
Chr16:79599021 [GRCh38] Chr16:79632918 [GRCh37] Chr16:16q23.2 |
benign|likely benign |
GRCh37/hg19 16q23.2(chr16:79632678-79633799)x1 |
copy number loss |
not provided [RCV002292937] |
Chr16:79632678..79633799 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1222C>G (p.Arg408Gly) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001223083]|Global developmental delay [RCV000449583] |
Chr16:79211773 [GRCh38] Chr16:79245670 [GRCh37] Chr16:16q23.2 |
uncertain significance |
GRCh37/hg19 16p13.3-q24.3(chr16:69193-90274381)x3 |
copy number gain |
See cases [RCV000446684] |
Chr16:69193..90274381 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
NM_016373.4(WWOX):c.1170C>T (p.Ser390=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV000475867]|not provided [RCV001584188] |
Chr16:79211721 [GRCh38] Chr16:79245618 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1057-4C>T |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV002063213]|not provided [RCV001722663] |
Chr16:79211604 [GRCh38] Chr16:79245501 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1073C>T (p.Thr358Ile) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV000650201] |
Chr16:79211624 [GRCh38] Chr16:79245521 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1131C>A (p.Asn377Lys) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV000650203]|Inborn genetic diseases [RCV004965636]|not provided [RCV003156275] |
Chr16:79211682 [GRCh38] Chr16:79245579 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1142G>T (p.Arg381Leu) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV000650204] |
Chr16:79211693 [GRCh38] Chr16:79245590 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1171G>A (p.Glu391Lys) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV000650208] |
Chr16:79211722 [GRCh38] Chr16:79245619 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1239C>G (p.Ser413=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV000650215]|WWOX-related disorder [RCV003953174] |
Chr16:79211790 [GRCh38] Chr16:79245687 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1155A>C (p.Ser385=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV000650216] |
Chr16:79211706 [GRCh38] Chr16:79245603 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.942C>T (p.His314=) |
single nucleotide variant |
Cataract 21 multiple types [RCV000652088] |
Chr16:79598961 [GRCh38] Chr16:79632858 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.295_312delinsTGCA (p.Gln99fs) |
indel |
Cataract 21 multiple types [RCV000652087] |
Chr16:79599591..79599608 [GRCh38] Chr16:79633488..79633505 [GRCh37] Chr16:16q23.2 |
pathogenic|uncertain significance |
NM_005360.5(MAF):c.619G>T (p.Ala207Ser) |
single nucleotide variant |
Inborn genetic diseases [RCV003253869] |
Chr16:79599284 [GRCh38] Chr16:79633181 [GRCh37] Chr16:16q23.2 |
likely benign |
GRCh37/hg19 16q11.2-24.3(chr16:46455960-90354753)x1 |
copy number loss |
Poly (ADP-Ribose) polymerase inhibitor response [RCV000626435] |
Chr16:46455960..90354753 [GRCh37] Chr16:16q11.2-24.3 |
drug response |
NM_016373.4(WWOX):c.1222C>T (p.Arg408Trp) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV000807071]|Self-limited epilepsy with centrotemporal spikes [RCV000656056]|not provided [RCV003128810] |
Chr16:79211773 [GRCh38] Chr16:79245670 [GRCh37] Chr16:16q23.2 |
pathogenic|uncertain significance |
NM_016373.4(WWOX):c.1196C>T (p.Ala399Val) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001057217]|Inborn genetic diseases [RCV002532966]|not provided [RCV000714204] |
Chr16:79211747 [GRCh38] Chr16:79245644 [GRCh37] Chr16:16q23.2 |
uncertain significance |
GRCh37/hg19 16q23.1-23.2(chr16:78156871-79792370)x3 |
copy number gain |
not provided [RCV000683842] |
Chr16:78156871..79792370 [GRCh37] Chr16:16q23.1-23.2 |
uncertain significance |
GRCh37/hg19 16q23.2-24.3(chr16:79400436-90155062)x3 |
copy number gain |
not provided [RCV000683845] |
Chr16:79400436..90155062 [GRCh37] Chr16:16q23.2-24.3 |
pathogenic |
GRCh37/hg19 16q22.2-24.3(chr16:72515938-90155062)x3 |
copy number gain |
not provided [RCV000683831] |
Chr16:72515938..90155062 [GRCh37] Chr16:16q22.2-24.3 |
pathogenic |
NM_016373.4(WWOX):c.1180G>A (p.Ala394Thr) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV000687773]|not provided [RCV002473105] |
Chr16:79211731 [GRCh38] Chr16:79245628 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.1118+176AC[17] |
microsatellite |
not provided [RCV001574896] |
Chr16:79598581..79598582 [GRCh38] Chr16:79632478..79632479 [GRCh37] Chr16:16q23.2 |
likely benign |
GRCh37/hg19 16p13.3-q24.3(chr16:88165-90274695)x3 |
copy number gain |
not provided [RCV000738918] |
Chr16:88165..90274695 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
GRCh37/hg19 16p13.3-q24.3(chr16:61451-90294632)x3 |
copy number gain |
not provided [RCV000738915] |
Chr16:61451..90294632 [GRCh37] Chr16:16p13.3-q24.3 |
pathogenic |
NM_016373.4(WWOX):c.1057-247T>C |
single nucleotide variant |
not provided [RCV001541380] |
Chr16:79211361 [GRCh38] Chr16:79245258 [GRCh37] Chr16:16q23.2 |
benign |
NM_016373.4(WWOX):c.*14C>T |
single nucleotide variant |
not provided [RCV001548697] |
Chr16:79211810 [GRCh38] Chr16:79245707 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.453C>A (p.Gly151=) |
single nucleotide variant |
Cataract 21 multiple types [RCV000877866] |
Chr16:79599450 [GRCh38] Chr16:79633347 [GRCh37] Chr16:16q23.2 |
likely benign |
NC_000016.10:g.(?_78278583)_(80589366_?)del |
deletion |
Cataract 21 multiple types [RCV000811355] |
Chr16:78278583..80589366 [GRCh38] Chr16:78312480..80623263 [GRCh37] Chr16:16q23.1-23.2 |
pathogenic |
NM_016373.4(WWOX):c.1118G>T (p.Gly373Val) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV000811373] |
Chr16:79211669 [GRCh38] Chr16:79245566 [GRCh37] Chr16:16q23.2 |
uncertain significance |
GRCh37/hg19 16q23.2(chr16:79570137-79636851)x3 |
copy number gain |
not provided [RCV000847873] |
Chr16:79570137..79636851 [GRCh37] Chr16:16q23.2 |
uncertain significance |
GRCh37/hg19 16q23.2-24.1(chr16:79254648-84827672)x1 |
copy number loss |
not provided [RCV000849998] |
Chr16:79254648..84827672 [GRCh37] Chr16:16q23.2-24.1 |
uncertain significance |
NM_016373.4(WWOX):c.*187_*190dup |
duplication |
Developmental and epileptic encephalopathy, 1 [RCV000989642] |
Chr16:79211982..79211983 [GRCh38] Chr16:79245879..79245880 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NC_000016.10:g.(?_79594440)_(79599922_?)del |
deletion |
Cataract 21 multiple types [RCV001031552] |
Chr16:79628337..79633819 [GRCh37] Chr16:16q23.2 |
pathogenic |
NM_005360.5(MAF):c.-30GGC[4] |
microsatellite |
Cataract 21 multiple types [RCV000989643]|not provided [RCV003424520] |
Chr16:79599909..79599920 [GRCh38] Chr16:79633806..79633817 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.1118+36A>T |
single nucleotide variant |
not provided [RCV001557278] |
Chr16:79598749 [GRCh38] Chr16:79632646 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1057-23dup |
duplication |
not provided [RCV001549749] |
Chr16:79211576..79211577 [GRCh38] Chr16:79245473..79245474 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.-526C>T |
single nucleotide variant |
not provided [RCV001561142] |
Chr16:79600428 [GRCh38] Chr16:79634325 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.*53C>A |
single nucleotide variant |
not provided [RCV001590570] |
Chr16:79211849 [GRCh38] Chr16:79245746 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.1118+176AC[15] |
microsatellite |
not provided [RCV001620777] |
Chr16:79598581..79598582 [GRCh38] Chr16:79632478..79632479 [GRCh37] Chr16:16q23.2 |
benign |
NM_005360.5(MAF):c.-282G>A |
single nucleotide variant |
not provided [RCV001545394] |
Chr16:79600184 [GRCh38] Chr16:79634081 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1117G>A (p.Gly373Arg) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001349756] |
Chr16:79211668 [GRCh38] Chr16:79245565 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1230C>G (p.Gly410=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001428261] |
Chr16:79211781 [GRCh38] Chr16:79245678 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.*185G>C |
single nucleotide variant |
not provided [RCV001691480] |
Chr16:79594275 [GRCh38] Chr16:79628172 [GRCh37] Chr16:16q23.2 |
benign |
NM_005360.5(MAF):c.185C>T (p.Thr62Met) |
single nucleotide variant |
Ayme-Gripp syndrome [RCV001775246]|Cataract 21 multiple types [RCV002541042] |
Chr16:79599718 [GRCh38] Chr16:79633615 [GRCh37] Chr16:16q23.2 |
likely pathogenic |
NM_005360.5(MAF):c.495C>T (p.Ser165=) |
single nucleotide variant |
not specified [RCV004800012] |
Chr16:79599408 [GRCh38] Chr16:79633305 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1148T>C (p.Met383Thr) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001893186] |
Chr16:79211699 [GRCh38] Chr16:79245596 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1165C>T (p.Gln389Ter) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001867230]|not provided [RCV002307770]|not specified [RCV003235606] |
Chr16:79211716 [GRCh38] Chr16:79245613 [GRCh37] Chr16:16q23.2 |
likely pathogenic|uncertain significance |
NM_016373.4(WWOX):c.1183C>G (p.Arg395Gly) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001980814] |
Chr16:79211734 [GRCh38] Chr16:79245631 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1122G>A (p.Met374Ile) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001954905] |
Chr16:79211673 [GRCh38] Chr16:79245570 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.895C>T (p.Arg299Cys) |
single nucleotide variant |
Cataract 21 multiple types [RCV001904986] |
Chr16:79599008 [GRCh38] Chr16:79632905 [GRCh37] Chr16:16q23.2 |
pathogenic |
NM_016373.4(WWOX):c.1057-2A>G |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001940463] |
Chr16:79211606 [GRCh38] Chr16:79245503 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1171G>C (p.Glu391Gln) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV001922098] |
Chr16:79211722 [GRCh38] Chr16:79245619 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1057-22_1057-20del |
deletion |
Developmental and epileptic encephalopathy, 1 [RCV002190817] |
Chr16:79211586..79211588 [GRCh38] Chr16:79245483..79245485 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1209G>A (p.Arg403=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV002090934] |
Chr16:79211760 [GRCh38] Chr16:79245657 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.*53C>T |
single nucleotide variant |
not provided [RCV002211363] |
Chr16:79211849 [GRCh38] Chr16:79245746 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.*150_*154dup |
duplication |
not provided [RCV002211364] |
Chr16:79211945..79211946 [GRCh38] Chr16:79245842..79245843 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1227T>C (p.Leu409=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV002172922] |
Chr16:79211778 [GRCh38] Chr16:79245675 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.456C>T (p.Gly152=) |
single nucleotide variant |
Cataract 21 multiple types [RCV002094523] |
Chr16:79599447 [GRCh38] Chr16:79633344 [GRCh37] Chr16:16q23.2 |
benign |
NM_005360.5(MAF):c.939A>G (p.Arg313=) |
single nucleotide variant |
Cataract 21 multiple types [RCV002121010] |
Chr16:79598964 [GRCh38] Chr16:79632861 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.810T>G (p.Ser270=) |
single nucleotide variant |
Cataract 21 multiple types [RCV002121011] |
Chr16:79599093 [GRCh38] Chr16:79632990 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1077C>G (p.Thr359=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV002139062] |
Chr16:79211628 [GRCh38] Chr16:79245525 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1128C>T (p.Phe376=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV002098259] |
Chr16:79211679 [GRCh38] Chr16:79245576 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1242C>T (p.Gly414=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV002199129] |
Chr16:79211793 [GRCh38] Chr16:79245690 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1057-18T>G |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV002143952] |
Chr16:79211590 [GRCh38] Chr16:79245487 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.696C>T (p.Gly232=) |
single nucleotide variant |
Cataract 21 multiple types [RCV002158089] |
Chr16:79599207 [GRCh38] Chr16:79633104 [GRCh37] Chr16:16q23.2 |
likely benign |
GRCh37/hg19 16q11.2-24.3(chr16:46503968-90155062)x3 |
copy number gain |
not provided [RCV002221458] |
Chr16:46503968..90155062 [GRCh37] Chr16:16q11.2-24.3 |
pathogenic |
NM_016373.4(WWOX):c.1206G>A (p.Glu402=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV002083864] |
Chr16:79211757 [GRCh38] Chr16:79245654 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.487G>C (p.Val163Leu) |
single nucleotide variant |
Ayme-Gripp syndrome [RCV002227637] |
Chr16:79599416 [GRCh38] Chr16:79633313 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.285C>A (p.Thr95=) |
single nucleotide variant |
Cataract 21 multiple types [RCV002154866]|not provided [RCV004598176] |
Chr16:79599618 [GRCh38] Chr16:79633515 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1057-17_1057-14del |
microsatellite |
Developmental and epileptic encephalopathy, 1 [RCV002158833] |
Chr16:79211587..79211590 [GRCh38] Chr16:79245484..79245487 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1200_1244dup (p.*415Tyrext*15) |
duplication |
Progressive myositis ossificans [RCV002254447] |
Chr16:79211750..79211751 [GRCh38] Chr16:79245647..79245648 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1129AAC[1] (p.Asn378del) |
microsatellite |
Neurodevelopmental delay [RCV002274439] |
Chr16:79211679..79211681 [GRCh38] Chr16:79245576..79245578 [GRCh37] Chr16:16q23.2 |
pathogenic |
GRCh37/hg19 16q22.2-24.3(chr16:71641395-90161959)x3 |
copy number gain |
Syndromic anorectal malformation [RCV002286607] |
Chr16:71641395..90161959 [GRCh37] Chr16:16q22.2-24.3 |
likely pathogenic |
NM_005360.5(MAF):c.899G>A (p.Gly300Asp) |
single nucleotide variant |
Cataract 21 multiple types [RCV002289450] |
Chr16:79599004 [GRCh38] Chr16:79632901 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.984C>G (p.Asp328Glu) |
single nucleotide variant |
Ayme-Gripp syndrome [RCV002289332] |
Chr16:79598919 [GRCh38] Chr16:79632816 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.712G>T (p.Gly238Cys) |
single nucleotide variant |
Ayme-Gripp syndrome [RCV002472127] |
Chr16:79599191 [GRCh38] Chr16:79633088 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.922A>G (p.Lys308Glu) |
single nucleotide variant |
Cataract 21 multiple types [RCV002302259] |
Chr16:79598981 [GRCh38] Chr16:79632878 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1119G>C (p.Gly373=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV002858721] |
Chr16:79211670 [GRCh38] Chr16:79245567 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.308C>A (p.Pro103His) |
single nucleotide variant |
Cataract 21 multiple types [RCV002880343] |
Chr16:79599595 [GRCh38] Chr16:79633492 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.594C>T (p.Gly198=) |
single nucleotide variant |
Cataract 21 multiple types [RCV002686125]|not provided [RCV003312060] |
Chr16:79599309 [GRCh38] Chr16:79633206 [GRCh37] Chr16:16q23.2 |
benign|likely benign |
NM_016373.4(WWOX):c.1182C>G (p.Ala394=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV002842241] |
Chr16:79211733 [GRCh38] Chr16:79245630 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.334G>T (p.Asp112Tyr) |
single nucleotide variant |
Inborn genetic diseases [RCV002773905] |
Chr16:79599569 [GRCh38] Chr16:79633466 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.914G>T (p.Cys305Phe) |
single nucleotide variant |
not provided [RCV002511841] |
Chr16:79598989 [GRCh38] Chr16:79632886 [GRCh37] Chr16:16q23.2 |
likely pathogenic |
NM_005360.5(MAF):c.604G>A (p.Ala202Thr) |
single nucleotide variant |
Inborn genetic diseases [RCV002864816] |
Chr16:79599299 [GRCh38] Chr16:79633196 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1103T>G (p.Leu368Arg) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV002755916] |
Chr16:79211654 [GRCh38] Chr16:79245551 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1057-22_1057-19del |
deletion |
Developmental and epileptic encephalopathy, 1 [RCV002858482] |
Chr16:79211585..79211588 [GRCh38] Chr16:79245482..79245485 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.897C>T (p.Arg299=) |
single nucleotide variant |
not provided [RCV002511842] |
Chr16:79599006 [GRCh38] Chr16:79632903 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.578A>C (p.His193Pro) |
single nucleotide variant |
Inborn genetic diseases [RCV002998566] |
Chr16:79599325 [GRCh38] Chr16:79633222 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1102C>T (p.Leu368=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV002923100] |
Chr16:79211653 [GRCh38] Chr16:79245550 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1059A>C (p.Gln353His) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV002866480] |
Chr16:79211610 [GRCh38] Chr16:79245507 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1163C>T (p.Ala388Val) |
single nucleotide variant |
not provided [RCV002510080] |
Chr16:79211714 [GRCh38] Chr16:79245611 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.902A>G (p.Tyr301Cys) |
single nucleotide variant |
Cataract 21 multiple types [RCV002824603] |
Chr16:79599001 [GRCh38] Chr16:79632898 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.586A>C (p.Thr196Pro) |
single nucleotide variant |
Inborn genetic diseases [RCV002998567] |
Chr16:79599317 [GRCh38] Chr16:79633214 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.655G>A (p.Gly219Ser) |
single nucleotide variant |
Cataract 21 multiple types [RCV002948492] |
Chr16:79599248 [GRCh38] Chr16:79633145 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1245A>C (p.Ter415Tyr) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV003007893] |
Chr16:79211796 [GRCh38] Chr16:79245693 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1242del (p.Ter415LysextTer?) |
deletion |
Developmental and epileptic encephalopathy, 1 [RCV002828502] |
Chr16:79211793 [GRCh38] Chr16:79245690 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.487G>A (p.Val163Met) |
single nucleotide variant |
Inborn genetic diseases [RCV002786863] |
Chr16:79599416 [GRCh38] Chr16:79633313 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.644G>A (p.Gly215Asp) |
single nucleotide variant |
Cataract 21 multiple types [RCV003056856] |
Chr16:79599259 [GRCh38] Chr16:79633156 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.760G>C (p.Gly254Arg) |
single nucleotide variant |
Inborn genetic diseases [RCV002699089] |
Chr16:79599143 [GRCh38] Chr16:79633040 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1183C>A (p.Arg395=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV002624639] |
Chr16:79211734 [GRCh38] Chr16:79245631 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.468G>C (p.Glu156Asp) |
single nucleotide variant |
Cataract 21 multiple types [RCV002928922] |
Chr16:79599435 [GRCh38] Chr16:79633332 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.705CGG[4] (p.Gly238_Ala239insGlyGly) |
microsatellite |
Cataract 21 multiple types [RCV002872794] |
Chr16:79599192..79599193 [GRCh38] Chr16:79633089..79633090 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.264G>A (p.Leu88=) |
single nucleotide variant |
Cataract 21 multiple types [RCV002900009] |
Chr16:79599639 [GRCh38] Chr16:79633536 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.641G>C (p.Gly214Ala) |
single nucleotide variant |
Cataract 21 multiple types [RCV002600695] |
Chr16:79599262 [GRCh38] Chr16:79633159 [GRCh37] Chr16:16q23.2 |
benign |
NM_016373.4(WWOX):c.1203C>G (p.Ser401Arg) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV003088262] |
Chr16:79211754 [GRCh38] Chr16:79245651 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1069G>A (p.Ala357Thr) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV002580597] |
Chr16:79211620 [GRCh38] Chr16:79245517 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1057-10G>C |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV002599735] |
Chr16:79211598 [GRCh38] Chr16:79245495 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.593G>A (p.Gly198Asp) |
single nucleotide variant |
Inborn genetic diseases [RCV002717643]|MAF-related disorder [RCV003900884] |
Chr16:79599310 [GRCh38] Chr16:79633207 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.678CGG[5] (p.Gly236_Gly238del) |
microsatellite |
Cataract 21 multiple types [RCV002963351] |
Chr16:79599202..79599210 [GRCh38] Chr16:79633099..79633107 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1232G>C (p.Ser411Thr) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV003050456] |
Chr16:79211783 [GRCh38] Chr16:79245680 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.544CAC[9] (p.His187_Ala188insHisHisHis) |
microsatellite |
Cataract 21 multiple types [RCV002944168] |
Chr16:79599341..79599342 [GRCh38] Chr16:79633238..79633239 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1060C>T (p.Gln354Ter) |
single nucleotide variant |
not provided [RCV003139367] |
Chr16:79211611 [GRCh38] Chr16:79245508 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.442G>T (p.Ala148Ser) |
single nucleotide variant |
not provided [RCV003134151] |
Chr16:79599461 [GRCh38] Chr16:79633358 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.1138T>A (p.Leu380Met) |
single nucleotide variant |
Inborn genetic diseases [RCV003286010] |
Chr16:79594534 [GRCh38] Chr16:79628431 [GRCh37] Chr16:16q23.2 |
uncertain significance |
GRCh37/hg19 16q22.1-23.2(chr16:70607067-81561138)x3 |
copy number gain |
not provided [RCV003485121] |
Chr16:70607067..81561138 [GRCh37] Chr16:16q22.1-23.2 |
pathogenic |
NM_005360.5(MAF):c.621C>A (p.Ala207=) |
single nucleotide variant |
not specified [RCV003405020] |
Chr16:79599282 [GRCh38] Chr16:79633179 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.391_392delinsCT (p.Tyr131Leu) |
indel |
not provided [RCV003456946] |
Chr16:79599511..79599512 [GRCh38] Chr16:79633408..79633409 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.*269G>A |
single nucleotide variant |
not provided [RCV004810092] |
Chr16:79212065 [GRCh38] Chr16:79245962 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.1079G>C (p.Gly360Ala) |
single nucleotide variant |
not provided [RCV004777315] |
Chr16:79598824 [GRCh38] Chr16:79632721 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.871C>G (p.Gln291Glu) |
single nucleotide variant |
Cataract 21 multiple types [RCV003487066] |
Chr16:79599032 [GRCh38] Chr16:79632929 [GRCh37] Chr16:16q23.2 |
likely pathogenic |
NM_005360.5(MAF):c.590C>G (p.Ala197Gly) |
single nucleotide variant |
not provided [RCV003426851] |
Chr16:79599313 [GRCh38] Chr16:79633210 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.862C>G (p.Arg288Gly) |
single nucleotide variant |
MAF-related disorder [RCV003408362] |
Chr16:79599041 [GRCh38] Chr16:79632938 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.1119-2A>G |
single nucleotide variant |
MAF-related disorder [RCV003404683] |
Chr16:79594555 [GRCh38] Chr16:79628452 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.435_440dup (p.Ala148_Ser149insGlyAla) |
duplication |
not specified [RCV003388346] |
Chr16:79599462..79599463 [GRCh38] Chr16:79633359..79633360 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.-30GGC[6] |
microsatellite |
not provided [RCV003426852] |
Chr16:79599909..79599914 [GRCh38] Chr16:79633806..79633811 [GRCh37] Chr16:16q23.2 |
benign|likely benign |
NM_016373.4(WWOX):c.*134C>T |
single nucleotide variant |
not provided [RCV003419462]|not specified [RCV003988114] |
Chr16:79211930 [GRCh38] Chr16:79245827 [GRCh37] Chr16:16q23.2 |
likely benign|uncertain significance |
NM_016373.4(WWOX):c.1122G>T (p.Met374Ile) |
single nucleotide variant |
not provided [RCV003426849] |
Chr16:79211673 [GRCh38] Chr16:79245570 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.*107G>A |
single nucleotide variant |
not provided [RCV003426850] |
Chr16:79211903 [GRCh38] Chr16:79245800 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.827G>C (p.Arg276Pro) |
single nucleotide variant |
not provided [RCV003441647] |
Chr16:79599076 [GRCh38] Chr16:79632973 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.206del (p.Pro69fs) |
deletion |
Cataract 21 multiple types [RCV004765817]|not provided [RCV003391163] |
Chr16:79599697 [GRCh38] Chr16:79633594 [GRCh37] Chr16:16q23.2 |
likely pathogenic |
NM_005360.5(MAF):c.861C>T (p.Ile287=) |
single nucleotide variant |
Cataract 21 multiple types [RCV003807691] |
Chr16:79599042 [GRCh38] Chr16:79632939 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1057-13_1057-11del |
microsatellite |
Developmental and epileptic encephalopathy, 1 [RCV003785046] |
Chr16:79211590..79211592 [GRCh38] Chr16:79245487..79245489 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1130A>G (p.Asn377Ser) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV003806659] |
Chr16:79211681 [GRCh38] Chr16:79245578 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.490_501del (p.Val164_Val167del) |
deletion |
Cataract 21 multiple types [RCV003791391] |
Chr16:79599402..79599413 [GRCh38] Chr16:79633299..79633310 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.892A>C (p.Asn298His) |
single nucleotide variant |
Cataract 21 multiple types [RCV003797833] |
Chr16:79599011 [GRCh38] Chr16:79632908 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.894C>A (p.Asn298Lys) |
single nucleotide variant |
Cataract 21 multiple types [RCV003782984] |
Chr16:79599009 [GRCh38] Chr16:79632906 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1236G>A (p.Gln412=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV003788970] |
Chr16:79211787 [GRCh38] Chr16:79245684 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1083C>T (p.Tyr361=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV003794716] |
Chr16:79211634 [GRCh38] Chr16:79245531 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.138C>T (p.Cys46=) |
single nucleotide variant |
Cataract 21 multiple types [RCV003787822] |
Chr16:79599765 [GRCh38] Chr16:79633662 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.592G>A (p.Gly198Ser) |
single nucleotide variant |
Cataract 21 multiple types [RCV003792754] |
Chr16:79599311 [GRCh38] Chr16:79633208 [GRCh37] Chr16:16q23.2 |
benign|uncertain significance |
NM_016373.4(WWOX):c.1113G>A (p.Leu371=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV003794699] |
Chr16:79211664 [GRCh38] Chr16:79245561 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1189C>T (p.Leu397=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV003796056] |
Chr16:79211740 [GRCh38] Chr16:79245637 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1057-7T>C |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV003795383] |
Chr16:79211601 [GRCh38] Chr16:79245498 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.678CGG[11] (p.Gly238_Ala239insGlyGlyGly) |
microsatellite |
Cataract 21 multiple types [RCV003788177] |
Chr16:79599201..79599202 [GRCh38] Chr16:79633098..79633099 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.726G>T (p.Ala242=) |
single nucleotide variant |
Cataract 21 multiple types [RCV003800470] |
Chr16:79599177 [GRCh38] Chr16:79633074 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1057-14_1057-13insTCTC |
insertion |
Developmental and epileptic encephalopathy, 1 [RCV003798990] |
Chr16:79211594..79211595 [GRCh38] Chr16:79245491..79245492 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.1119-12T>C |
single nucleotide variant |
Cataract 21 multiple types [RCV003799023] |
Chr16:79594565 [GRCh38] Chr16:79628462 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1057-9G>C |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV003799759] |
Chr16:79211599 [GRCh38] Chr16:79245496 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1230C>A (p.Gly410=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV003803577] |
Chr16:79211781 [GRCh38] Chr16:79245678 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.823_834del (p.Asn275_Leu278del) |
deletion |
Cataract 21 multiple types [RCV003802827] |
Chr16:79599069..79599080 [GRCh38] Chr16:79632966..79632977 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.678CGG[6] (p.Gly237_Gly238del) |
microsatellite |
Cataract 21 multiple types [RCV003802616] |
Chr16:79599202..79599207 [GRCh38] Chr16:79633099..79633104 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.376G>T (p.Gly126Cys) |
single nucleotide variant |
not specified [RCV004527259] |
Chr16:79599527 [GRCh38] Chr16:79633424 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.895C>G (p.Arg299Gly) |
single nucleotide variant |
MAF-related disorder [RCV003982772] |
Chr16:79599008 [GRCh38] Chr16:79632905 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.726G>A (p.Ala242=) |
single nucleotide variant |
MAF-related disorder [RCV003932123] |
Chr16:79599177 [GRCh38] Chr16:79633074 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.192dup (p.Ser65fs) |
duplication |
MAF-related disorder [RCV003911833] |
Chr16:79599710..79599711 [GRCh38] Chr16:79633607..79633608 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.1137G>A (p.Lys379=) |
single nucleotide variant |
not provided [RCV003887757] |
Chr16:79594535 [GRCh38] Chr16:79628432 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.240G>C (p.Ser80=) |
single nucleotide variant |
MAF-related disorder [RCV003976886] |
Chr16:79599663 [GRCh38] Chr16:79633560 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.*162G>C |
single nucleotide variant |
not provided [RCV003886252] |
Chr16:79211958 [GRCh38] Chr16:79245855 [GRCh37] Chr16:16q23.2 |
likely benign |
NC_000016.9:g.(?_78420737)_(81991603_?)del |
deletion |
Developmental and epileptic encephalopathy, 1 [RCV004582743] |
Chr16:78420737..81991603 [GRCh37] Chr16:16q23.1-23.3 |
pathogenic |
NM_005360.5(MAF):c.378C>A (p.Gly126=) |
single nucleotide variant |
not provided [RCV004598910] |
Chr16:79599525 [GRCh38] Chr16:79633422 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1193G>A (p.Trp398Ter) |
single nucleotide variant |
not provided [RCV004585911] |
Chr16:79211744 [GRCh38] Chr16:79245641 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.1009C>T (p.Leu337=) |
single nucleotide variant |
not provided [RCV004585900] |
Chr16:79598894 [GRCh38] Chr16:79632791 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.*385G>A |
single nucleotide variant |
not specified [RCV004595454] |
Chr16:79212181 [GRCh38] Chr16:79246078 [GRCh37] Chr16:16q23.2 |
benign |
NM_005360.5(MAF):c.866T>G (p.Leu289Arg) |
single nucleotide variant |
not provided [RCV004770621] |
Chr16:79599037 [GRCh38] Chr16:79632934 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.892A>T (p.Asn298Tyr) |
single nucleotide variant |
not provided [RCV004766317] |
Chr16:79599011 [GRCh38] Chr16:79632908 [GRCh37] Chr16:16q23.2 |
pathogenic |
NM_005360.5(MAF):c.1181A>T (p.His394Leu) |
single nucleotide variant |
not specified [RCV004699883] |
Chr16:79594491 [GRCh38] Chr16:79628388 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.915C>G (p.Cys305Trp) |
single nucleotide variant |
MAF-related disorder [RCV004730809] |
Chr16:79598988 [GRCh38] Chr16:79632885 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.582C>T (p.His194=) |
single nucleotide variant |
not specified [RCV004766641] |
Chr16:79599321 [GRCh38] Chr16:79633218 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.82A>C (p.Met28Leu) |
single nucleotide variant |
not provided [RCV004769678] |
Chr16:79599821 [GRCh38] Chr16:79633718 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.779G>C (p.Arg260Pro) |
single nucleotide variant |
not provided [RCV004724123] |
Chr16:79599124 [GRCh38] Chr16:79633021 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.1169G>A (p.Trp390Ter) |
single nucleotide variant |
not provided [RCV004775774] |
Chr16:79594503 [GRCh38] Chr16:79628400 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.916C>T (p.Arg306Cys) |
single nucleotide variant |
not provided [RCV004721761] |
Chr16:79598987 [GRCh38] Chr16:79632884 [GRCh37] Chr16:16q23.2 |
likely pathogenic |
NM_005360.5(MAF):c.72C>G (p.Asp24Glu) |
single nucleotide variant |
MAF-related disorder [RCV004730449] |
Chr16:79599831 [GRCh38] Chr16:79633728 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.164T>C (p.Leu55Pro) |
single nucleotide variant |
Inborn genetic diseases [RCV004990417] |
Chr16:79599739 [GRCh38] Chr16:79633636 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.640G>A (p.Gly214Arg) |
single nucleotide variant |
Inborn genetic diseases [RCV004990420] |
Chr16:79599263 [GRCh38] Chr16:79633160 [GRCh37] Chr16:16q23.2 |
uncertain significance |
GRCh37/hg19 16q21-24.1(chr16:62746020-84485022)x3 |
copy number gain |
not provided [RCV004819314] |
Chr16:62746020..84485022 [GRCh37] Chr16:16q21-24.1 |
pathogenic |
NM_005360.5(MAF):c.675_683dup (p.Gly238_Ala239insGlyGlyGly) |
duplication |
Cataract 21 multiple types [RCV005210787] |
Chr16:79599219..79599220 [GRCh38] Chr16:79633116..79633117 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1164T>G (p.Ala388=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV005226558] |
Chr16:79211715 [GRCh38] Chr16:79245612 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.576C>T (p.His192=) |
single nucleotide variant |
Cataract 21 multiple types [RCV005229198] |
Chr16:79599327 [GRCh38] Chr16:79633224 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.588G>A (p.Thr196=) |
single nucleotide variant |
Cataract 21 multiple types [RCV005224982] |
Chr16:79599315 [GRCh38] Chr16:79633212 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.386A>G (p.Asp129Gly) |
single nucleotide variant |
not specified [RCV005238649] |
Chr16:79599517 [GRCh38] Chr16:79633414 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1190T>G (p.Leu397Arg) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV005215751] |
Chr16:79211741 [GRCh38] Chr16:79245638 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.535C>T (p.Pro179Ser) |
single nucleotide variant |
not specified [RCV005240199] |
Chr16:79599368 [GRCh38] Chr16:79633265 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1062G>A (p.Gln354=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV005217880] |
Chr16:79211613 [GRCh38] Chr16:79245510 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.647C>G (p.Ala216Gly) |
single nucleotide variant |
Cataract 21 multiple types [RCV005219542] |
Chr16:79599256 [GRCh38] Chr16:79633153 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1057-10G>T |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV005219035] |
Chr16:79211598 [GRCh38] Chr16:79245495 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.1097del (p.Pro366fs) |
deletion |
not provided [RCV005250914] |
Chr16:79598806 [GRCh38] Chr16:79632703 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1176G>T (p.Glu392Asp) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV002009820] |
Chr16:79211727 [GRCh38] Chr16:79245624 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NC_000016.9:g.(?_78133676)_(79633799_?)del |
deletion |
Developmental and epileptic encephalopathy, 1 [RCV003119738] |
Chr16:78133676..79633799 [GRCh37] Chr16:16q23.1-23.2 |
pathogenic |
NM_005360.5(MAF):c.959A>G (p.Lys320Arg) |
single nucleotide variant |
not provided [RCV003154144] |
Chr16:79598944 [GRCh38] Chr16:79632841 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.731G>T (p.Gly244Val) |
single nucleotide variant |
not provided [RCV002276398] |
Chr16:79599172 [GRCh38] Chr16:79633069 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.610G>A (p.Gly204Ser) |
single nucleotide variant |
not specified [RCV003231008] |
Chr16:79599293 [GRCh38] Chr16:79633190 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1156C>T (p.Pro386Ser) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV002297510] |
Chr16:79211707 [GRCh38] Chr16:79245604 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1112T>G (p.Leu371Arg) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV002298341] |
Chr16:79211663 [GRCh38] Chr16:79245560 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.828G>A (p.Arg276=) |
single nucleotide variant |
Cataract 21 multiple types [RCV002842747]|not provided [RCV003992683] |
Chr16:79599075 [GRCh38] Chr16:79632972 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.705CGG[3] (p.Gly238_Ala239insGly) |
microsatellite |
Cataract 21 multiple types [RCV002695340]|not provided [RCV003418586] |
Chr16:79599192..79599193 [GRCh38] Chr16:79633089..79633090 [GRCh37] Chr16:16q23.2 |
benign|likely benign|uncertain significance |
NM_005360.5(MAF):c.935A>G (p.Gln312Arg) |
single nucleotide variant |
Cataract 21 multiple types [RCV003018525] |
Chr16:79598968 [GRCh38] Chr16:79632865 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1178C>G (p.Thr393Arg) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV002890863] |
Chr16:79211729 [GRCh38] Chr16:79245626 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.547C>A (p.His183Asn) |
single nucleotide variant |
Inborn genetic diseases [RCV002983653]|not provided [RCV003427648] |
Chr16:79599356 [GRCh38] Chr16:79633253 [GRCh37] Chr16:16q23.2 |
likely benign|uncertain significance |
NM_016373.4(WWOX):c.1067C>T (p.Ala356Val) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV003028994] |
Chr16:79211618 [GRCh38] Chr16:79245515 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1110T>G (p.Gly370=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV002577325] |
Chr16:79211661 [GRCh38] Chr16:79245558 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.866T>A (p.Leu289Gln) |
single nucleotide variant |
Cataract 21 multiple types [RCV002832755] |
Chr16:79599037 [GRCh38] Chr16:79632934 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.478G>A (p.Ala160Thr) |
single nucleotide variant |
Inborn genetic diseases [RCV002719204] |
Chr16:79599425 [GRCh38] Chr16:79633322 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1218A>G (p.Gln406=) |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV002937495] |
Chr16:79211769 [GRCh38] Chr16:79245666 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.1057-20C>T |
single nucleotide variant |
Developmental and epileptic encephalopathy, 1 [RCV003068086] |
Chr16:79211588 [GRCh38] Chr16:79245485 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_016373.4(WWOX):c.*46C>T |
single nucleotide variant |
not provided [RCV003326945] |
Chr16:79211842 [GRCh38] Chr16:79245739 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.860T>G (p.Ile287Ser) |
single nucleotide variant |
Cataract 21 multiple types [RCV003336035] |
Chr16:79599043 [GRCh38] Chr16:79632940 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.1050G>A (p.Lys350=) |
single nucleotide variant |
not specified [RCV003331697] |
Chr16:79598853 [GRCh38] Chr16:79632750 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.260A>C (p.His87Pro) |
single nucleotide variant |
Cataract 21 multiple types [RCV003791378] |
Chr16:79599643 [GRCh38] Chr16:79633540 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.695G>T (p.Gly232Val) |
single nucleotide variant |
not provided [RCV003457258] |
Chr16:79599208 [GRCh38] Chr16:79633105 [GRCh37] Chr16:16q23.2 |
uncertain significance |
GRCh38/hg38 16q23.2-23.3(chr16:79568000-83552000) |
copy number loss |
CMIP-related neurodevelopmental disorder [RCV003448630] |
Chr16:79568000..83552000 [GRCh38] Chr16:16q23.2-23.3 |
likely pathogenic |
NM_005360.5(MAF):c.848AGG[2] (p.Glu285del) |
microsatellite |
MAF-related disorder [RCV003402816] |
Chr16:79599047..79599049 [GRCh38] Chr16:79632944..79632946 [GRCh37] Chr16:16q23.2 |
likely pathogenic |
NM_005360.5(MAF):c.817G>A (p.Glu273Lys) |
single nucleotide variant |
not provided [RCV005054749] |
Chr16:79599086 [GRCh38] Chr16:79632983 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.598C>A (p.Pro200Thr) |
single nucleotide variant |
MAF-related disorder [RCV003894318] |
Chr16:79599305 [GRCh38] Chr16:79633202 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.197C>T (p.Ser66Leu) |
single nucleotide variant |
Ayme-Gripp syndrome [RCV004759644] |
|
pathogenic|likely pathogenic |
NM_005360.5(MAF):c.306C>A (p.Asn102Lys) |
single nucleotide variant |
not provided [RCV004771202] |
Chr16:79599597 [GRCh38] Chr16:79633494 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.483C>T (p.Ala161=) |
single nucleotide variant |
MAF-related disorder [RCV004755331] |
Chr16:79599420 [GRCh38] Chr16:79633317 [GRCh37] Chr16:16q23.2 |
likely benign |
NM_005360.5(MAF):c.1150G>T (p.Val384Leu) |
single nucleotide variant |
Inborn genetic diseases [RCV004990419] |
Chr16:79594522 [GRCh38] Chr16:79628419 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_005360.5(MAF):c.641G>T (p.Gly214Val) |
single nucleotide variant |
Inborn genetic diseases [RCV004990418] |
Chr16:79599262 [GRCh38] Chr16:79633159 [GRCh37] Chr16:16q23.2 |
uncertain significance |
NM_016373.4(WWOX):c.1079T>G (p.Val360Gly) |
single nucleotide variant |
not provided [RCV005052419] |
Chr16:79211630 [GRCh38] Chr16:79245527 [GRCh37] Chr16:16q23.2 |
uncertain significance |
GRCh37/hg19 16q23.2(chr16:79590617-81362574)x1 |
copy number loss |
not provided [RCV004819883] |
Chr16:79590617..81362574 [GRCh37] Chr16:16q23.2 |
uncertain significance |